People: DexCom Inc (DXCM.OQ)
18 Apr 2019
Mr. Andrew K. Balo serves as Executive Vice President - Regulatory Strategy, Clinical Affairs, and Strategic Partnership Development of DexCom Inc. He has served as our Executive Vice President of Regulatory Strategy, Clinical Affairs, and Strategic Partnership Development since May 2016. From January 2015 until April 2016 Mr. Balo served as our Executive Vice President, Clinical, Regulatory and Quality. From March 2008 to January 2015, Mr. Balo served as our Senior Vice President of Clinical and Regulatory Affairs, and from February 2002 to March 2008, served as our Vice President of Clinical and Regulatory Affairs. From June 1999 to February 2002, Mr. Balo served as Vice President, Regulatory and Clinical Affairs of Innercool Therapies, Inc., a medical technology company. Mr. Balo has held several positions at St. Jude Medical including Clinical, Vice President, Quality, Regulatory and Clinical Affairs and was an officer of the company. Mr. Balo received a B.S. from the University of Maryland.
|Total Annual Compensation, USD||744,354|
|Restricted Stock Award, USD||2,250,230|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||22,325|
|Fiscal Year Total, USD||3,016,910|